Australian Gonococcal Surveillance Programme, 1 April to 30 June 2014

Authors

  • Monica M Lahra World Health Organization Collaborating Centre for STI and AMR, Sydney and Neisseria Reference Laboratory, NSW Health Pathology Microbiology, Prince of Wales Hospital, Randwick, NSW 2031, Australia; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Kensington, NSW 2052, Australia
  • Australian Gonococcal Surveillance Programme

DOI:

https://doi.org/10.33321/cdi.2014.38.61

Keywords:

antimicrobial resistance, disease surveillance, gonococcal infection, Neisseria gonorrhoeae

Abstract

The Australian National Neisseria Network (NNN) comprises reference laboratories in each state and territory that report data on sensitivity to an agreed group of antimicrobial agents for the Australian Gonococcal Surveillance Programme (AGSP). The AGSP data are presented quarterly in tabulated form, as well as in the AGSP annual report. This report presents national gonococcal antimicrobial resistance surveillance data for the indicated quarter.

Downloads

Download data is not yet available.

References

Surveillance of antibiotic susceptibility of Neisseria gonorrhoeae in the WHO western Pacific region 1992–4. WHO Western Pacific Region Gonococcal Antimicrobial Surveillance Programme. 1997.

Speers DJ, Fisk RE, Goire N, Mak DB. Non-culture Neisseria gonorrhoeae molecular penicillinase production surveillance demonstrates the long-term success of empirical dual therapy and informs gonorrhoea management guidelines in a highly endemic setting. J Antimicrob Chemother 2014;69(5):1243–1247.

Goire N, Freeman K, Tapsall JW, Lambert SB, Nissen MD, Sloots TP, et al. Enhancing gonococcal antimicrobial resistance surveillance: a real-time PCR assay for detection of penicillinase-producing Neisseria gonorrhoeae by use of noncultured clinical samples. J Clin Microbiol 2011;49(2):513–518.

Lahra MM. Australian Gonococcal Surveillance Programme annual report, 2013. Commun Dis Intell In press.

Goire N, Lahra MM, Chen M, Donovan B, Fairley CK, Guy R, et al. Molecular approaches to enhance surveillance of gonococcal antimicrobial resistance. 2014.

Chen YM, Stevens K, Tideman R, Zaia A, Tomita T, Fairley CK, et al. Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia. J Antimicro Chemother 2013;68(6):1445–1447.

Read PJ, Limnios EA, McNulty A, Whiley D, Lahra MM. One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500 mg ceftriaxone in Sydney, Australia. Sex Health 2013;10(5):460–462.

Australasian Sexual Health Alliance. The Australian Sexually Transmitted Infection Management Guidelines 2014. [online] Available from: www.sti.guidelines.org.au

Downloads

Published

01/12/14

How to Cite

Lahra, Monica M, and Australian Gonococcal Surveillance Programme. 2014. “Australian Gonococcal Surveillance Programme, 1 April to 30 June 2014”. Communicable Diseases Intelligence 38 (December):390-92. https://doi.org/10.33321/cdi.2014.38.61.

Most read articles by the same author(s)

<< < 5 6 7 8 9 10 11 12 13 > >>